Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 480
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,461 Results (Page 60 of 124)
- Relevance
  Sort by

T-Cell Lymphoma - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
132 Pages
Global

From

€4690EUR$4,750USD£3,917GBP

Non-Hodgkin Lymphoma Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
112 Pages
Global

From

€4690EUR$4,750USD£3,917GBP

Non-Hodgkin Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

 Report
February 2024
130 Pages
Global

From

€4443EUR$4,500USD£3,710GBP

Lymphoma Treatment Market Report by Type, Test Type, Drug, and Region 2024-2032

 Report
August 2024
146 Pages
Global

From

€3850EUR$3,899USD£3,215GBP

Multiple Myeloma Drugs Market Report by Therapy, Drug Type, End-User, Distribution Channel, and Region 2024-2032

 Report
August 2024
138 Pages
Global

From

€3850EUR$3,899USD£3,215GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Drugs For Benign Prostatic hypertrophy Global Market Report 2024

 Report
November 2023
175 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Prostate Cancer Drugs Global Market Report 2024

 Report
November 2023
175 Pages
Global

From

€4937EUR$5,000USD£4,123GBP

Acute Myeloid Leukemia - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

 Report
February 2024
137 Pages
Global

From

€4690EUR$4,750USD£3,917GBP

Ewing Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
204 Pages
Global

From

€1975EUR$2,000USD£1,649GBP

Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
94 Pages
Global

From

€1975EUR$2,000USD£1,649GBP

Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
195 Pages
Global

From

€1975EUR$2,000USD£1,649GBP

Triple Negative Breast Cancer Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
November 2023
224 Pages
Global

€4932EUR$4,995USD£4,119GBP

Autism - Global Clinical Trials Review, 2022

 Clinical Trials
January 2022
419 Pages
Global

From

€2469EUR$2,500USD£2,061GBP

Rheumatology Therapeutics - Global Strategic Business Report

 Report
November 2024
196 Pages
Global

From

€5382EUR$5,450USD£4,494GBP

Asia-Pacific Sodium-dependent Glucose Cotransporter 2 (SGLT-2) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

 Report
February 2024
90 Pages
Asia Pacific

From

€4690EUR$4,750USD£3,917GBP

Europe Sodium-dependent Glucose Cotransporter 2 - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

 Report
February 2024
90 Pages
Europe

From

€4690EUR$4,750USD£3,917GBP

Sodium-dependent Glucose Co-transporter 2 (SGLT 2) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
100 Pages
Global

From

€4690EUR$4,750USD£3,917GBP

Acute Myeloid Leukemia Therapeutics Market Report by Treatment Type, Drug Type, Route of Administration, and Region 2024-2032

 Report
August 2024
141 Pages
Global

From

€3850EUR$3,899USD£3,215GBP

Drug Manufacturing Sector Scorecard - Thematic Intelligence

 Report
October 2022
23 Pages
Global

From

€1926EUR$1,950USD£1,608GBP

Irritable Bowel Disease Market (2024 Edition): Analysis By Drug Class (Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes), By Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

 Report
March 2024
250 Pages
Global

From

€2419EUR$2,450USD£2,020GBP

2,461 Results (Page 60 of 124)
- 1
- 58
- 59
- 60
- 61
- 62

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.